We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Egypt Explains Submission Status for Parenteral Biologicals Changes
Egypt Explains Submission Status for Parenteral Biologicals Changes
June 12, 2013
Egypt’s Central Administration for Pharmaceutical Affairs has issued guidelines for determining when a change in parenteral biological preparations should be submitted as a new application or a variation.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor